Southern Illinois University School of Medicine, MD 2012
Southern Illinois University School of Law, JD 2012
Harvard T.H. Chan School of Public Health, MPH 2015
Dr. Michael Sinha is a Regulatory Science Fellow in the new Harvard-MIT Center for Regulatory Science, within the Harvard Program in Therapeutic Science (HiTS) at Harvard Medical School. He is also affiliated with the Program On Regulation, Therapeutics, And Law (PORTAL), within the Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine at Brigham and Women’s Hospital. His legal scholarship includes articles in the American Journal of Legal Medicine, the American Journal of Law and Medicine, the Journal of Law, Medicine & Ethics, the Harvard Law & Policy Review, the Food & Drug Law Journal, the Stanford Law & Policy Review and the Hastings Law Journal (forthcoming). Medical publications have appeared in JAMA, JAMA Internal Medicine, CHEST, PLOS Medicine, the American Journal of Bioethics, Drug Safety, Mayo Clinic Proceedings (forthcoming), and the Health Affairs Blog. Research interests include FDA and pharmaceutical law, intellectual property law and antitrust law.